posterior capsular opacification
Conditions
Interventions
posterior capsule opacification group:NA
Sponsors
Tianjin Medical University Eye Hospital
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients who have undergone cataract surgery at least three months ago and who have given their informed and voluntary consent to participate in this study; 2.Aged 50 or over; gender not restricted; 3.Understand and sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1.Retinal diseases: diabetic retinopathy (DR), macular diseases, retinitis pigmentosa, and severe optic nerve diseases. 2.Patients who have undergone refractive surgery or have a history of eye trauma; 3.Corneal lesions, abnormal tear film function, marked pupillary abnormalities, active ocular inflammation, marked abnormalities of the lens suspensory ligaments, patients with amblyopia, patients with concomitant systemic diseases, etc. 4.Patients in whom a rupture of the suspensory ligament is discovered during surgery, or those experiencing severe intraoperative or postoperative complications;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| best corrected vision; | — |
Secondary
| Measure | Time frame |
|---|---|
| area of posterior capsule opacification;Dysfunctional Lens Index;Objective Scattering Index; | — |
Countries
China
Contacts
Public ContactJiang Yuanfeng
Tianjin Medical University Eye Hospital
Outcome results
None listed